Epigenome
 |
This article or section reads like a news release, or is otherwise written in an overly promotional tone. Please help by either rewriting this article from a neutral point of view or by moving this article to Wikinews. When appropriate, blatant advertising may be marked for speedy deletion with {{db-spam}}. (August 2011) |
 |
This article's tone or style may not reflect the formal tone used on Wikipedia. Specific concerns may be found on the talk page. See Wikipedia's guide to writing better articles for suggestions. (August 2011) |
An Epigenome consists of a record of the chemical changes to the DNA and histone proteins of an organism; these changes can be passed down to an organism's offspring. Changes to the epigenome can result in changes to the structure of chromatin and changes to the function of the genome.[1] Epigenetics is one of the current topics in cancer research drawing active research. Human tumors undergo a major disruption of DNA methylation and histone modification patterns. The aberrant epigenetic landscape of the cancer cell is characterized by a large genomic hypomethylation, CpG island promoter hypermethylation of tumor suppressor genes, an altered histone code for critical genes and a global loss of monoacetylated and trimethylated histone H4.
Much of the subject matter is not yet fully understood. Some people have suggested a Human Epigenome Project.[2]
[edit] Human Epigenome Pilot Project
The Human Epigenome Consortium is a public/private collaboration that aims to identify and catalogue Methylation Variable Positions (MVPs) in the human genome. As a prelude to the full-scale Human Epigenome Project (HEP), scientists have recently completed a pilot study of the methylation patterns within the Major Histocompatibility Complex (MHC) - a region of chromosome 6 that is associated with more diseases than any other region in the human genome.[citation needed] They claim to have identified MVPs in the vicinity of the promoter and other relevant regions of approximately 150 loci within the MHC in tissues from a range of individuals. This will provide an unprecedented insight into the complex relationship between genetics and epigenetics that underlies both normal cellular homeostasis and disease states, in particular autoimmune diseases. [3]
For the pilot project, we developed an integrated genomics-based technology platform. The pipeline involves the automated bisulphite treatment of DNA from minute tissue biopsies, gene-specific bisulphite PCR and large-scale sequencing of PCR amplicons. Analysis and quantification of methylation patterns is achieved by mass spectrometric and microarray assays.
One thing that still puzzles scientists is whether or not we can change our phenotype, characteristics that reflect our genes(genotype), but not our genotype.
[edit] References
- ^ Bernstein, Bradley E.; Meissner, Alexander; Lander,Eric S. (February 2007). "The Mammalian Epigenome". Cell 128 (4): 669–681. doi:10.1016/j.cell.2007.01.033. http://www.sciencedirect.com/science/article/pii/S0092867407001286. Retrieved 19 December 2011.
- ^ Jones, Peter A.; Martienssen, Robert (December 15, 2005). "A Blueprint for a Human Epigenome Project: The AACR Human Epigenome Workshop". Cancer Research 65 (24): 11241. doi:10.1158/0008-5472.CAN-05-3865. PMID 16357125. http://cancerres.aacrjournals.org/content/65/24/11241.short. Retrieved 19 December 2011.
- ^ Human Epigenome Project
